<http://schema.org/articleBody>
" Men with prostate cancer appear to face a heightened risk of blood clots, particularly if they are receiving hormone therapy, UK scientists have said. A team at King&amp;#039;s College London compared a group of Swedish men with prostate cancer with healthy members of the general population. Their study involved 30,642 men who received hormone therapy; 26,432 who were given curative treatment; and a further 19,526 who received surveillance. Between 1997 and 2007, a total of 1,881 blood clots were reported and the researchers found that men with prostate cancer were much more likely to develop clots than those who were cancer-free. Furthermore, they noticed that men receiving hormone therapy were 2.5 times more likely to develop deep vein thrombosis than those without prostate cancer. Writing in the journal the Lancet Oncology, the researchers observed: &amp;#039;Our findings indicate that it is important to consider thromboembolic side-effects when treating patients with prostate cancer, especially those who require endocrine (hormonal) treatment.&amp;#039; Prostate cancer is the most common form of cancer in UK men, accounting for one-quarter of all new cases of the disease. More than 35,000 men were diagnosed with the disease in the UK in 2006, according to Cancer Research UK. "^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.netdoctor.co.uk/healthy-living/news/a19427/prostate-cancer-linked-to-increased-blood-clot-risk/>